⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Advises Shareholders of Class Action Filing Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
globenewswire.com
VTGN
Pomerantz LLP Advises Shareholders of Class Action Filing Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
Pomerantz LLP Advises Shareholders of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Advises Shareholders of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics Ready to Announce with Confidence?
newsfilecorp.com
VTGN
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Advises of Securities Class Action Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN